Trial intelligence / Profile preview

Letrozole vs artificial estradiol cycle for frozen embryo transfer in women with PCOS

ChiCTR2200062244Phase 4Not yet recruiting

Sponsor
Guangdong Provincial People's Hospital
Start
Aug 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of letrozole in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoints: clinical pregnancy rate and abortion rate. Planned start Aug 2022; status: not yet recruiting.

02

Drugs

letrozole
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on ChiCTR2200062244.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200062244.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call